Clinical Trial Update: Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and efficacy of baricitinib for skin tightening in diffuse cutaneous systemic sclerosis, compared with methotrexate; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis

Drugs mentioned

• Baricitinib (baricitinib)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Diffuse Cutaneous Systemic Sclerosis | Phase 3 | Status: RECRUITING